Elicio Therapeutics
Alaina Ownbey, CPA, possesses extensive experience in accounting and financial reporting, having held key positions at several prominent companies. Currently serving as Controller at Elicio Therapeutics, Alaina previously worked at Skyhawk Therapeutics as Director and Associate Director of Technical Accounting & Reporting. Alaina also served as Associate Director of Technical Accounting & Reporting at Dragonfly Therapeutics, Inc., and held the role of Senior Manager in Accounting and Reporting Advisory at Deloitte. Earlier in the career, Alaina was Senior Revenue Recognition Manager and North America Revenue Recognition Manager at PTC. Alaina Ownbey earned both a Master’s and a Bachelor of Science in Accounting from Babson College.
Elicio Therapeutics
1 followers
Elicio is committed to transforming the lives of patients and their families by re-engineering the body’s immune response to cancer.